Marinomed Biotech AG buy Savour
Start price
06.03.21
/
0%
€143.00
Target price
06.03.22
-
Performance (%)
-37.76%
End price
21.12.21
€89.00
Summary
This prediction ended on 21.12.21 with a price of €89.00. Massive losses of -37.76% were the result for the BUY prediction by Savour. This prediction was marked as speculative and is excluded from Savour's performance statistics.Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Marinomed Biotech AG | - | - | - | - |
| iShares Core DAX® | 0.437% | 5.897% | 8.047% | 65.579% |
| iShares Nasdaq 100 | 1.057% | 0.920% | 28.466% | 90.185% |
| iShares Nikkei 225® | 1.769% | 1.228% | 47.574% | 84.991% |
| iShares S&P 500 | 0.368% | 1.920% | 23.200% | 70.760% |
According to Savour what are the pros and cons of Marinomed Biotech AG for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by Savour for this prediction
In the thread Marinomed Biotech AG diskutieren
Buy Marinomed Biotech AG